Validation Data Gallery
Tested Applications
| Positive WB detected in | human liver tissue, A549 cells | 
| Positive IHC detected in | human ovary tumor tissue,  human gliomas tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 | 
Recommended dilution
| Application | Dilution | 
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 | 
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Published Applications
| KD/KO | See 1 publications below | 
| WB | See 2 publications below | 
| IHC | See 1 publications below | 
Product Information
11218-1-AP targets TCEAL7 in WB, IHC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human | 
| Cited Reactivity | human | 
| Host / Isotype | Rabbit / IgG | 
| Class | Polyclonal | 
| Type | Antibody | 
| Immunogen | CatNo: Ag1715 Product name: Recombinant human TCEAL7 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-100 aa of BC016786 Sequence: MQKPCKENEGKPKCSVPKREEKRPYGEFERQQTEGNFRQRLLQSLEEFKEDIDYRHFKDEEMTREGDEMERCLEEIRGLRKKFRALHSNHRHSRDRPYPI相同性解析による交差性が予測される生物種 | 
| Full Name | transcription elongation factor A (SII)-like 7 | 
| Calculated molecular weight | 12 kDa | 
| Observed molecular weight | 12 kDa | 
| GenBank accession number | BC016786 | 
| Gene Symbol | TCEAL7 | 
| Gene ID (NCBI) | 56849 | 
| RRID | AB_2201131 | 
| Conjugate | Unconjugated | 
| Form | |
| Form | Liquid | 
| Purification Method | Antigen affinity purification | 
| UNIPROT ID | Q9BRU2 | 
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol{{ptg:BufferTemp}}7.3 | 
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. | 
Background Information
TCEAL7 is a transcription regulatory factor that has a role in the negative regulation of NF-kappa-B signaling at the basal level by regulating transcriptional activity of NF-kappa-B on its target gene promoters. It can associate with cyclin D1 promoter containing Myc E-box sequence and transcriptionally represses cyclin D1 expression. In addition, TCEAL7 regulates telomerase reverse transcriptase expression and telomerase activity in both ALT (alternative lengthening of telomeres)and telomerase-positive cell lines
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for TCEAL7 antibody 11218-1-AP | Download protocol | 
| WB protocol for TCEAL7 antibody 11218-1-AP | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 
Publications
| Species | Application | Title | 
|---|---|---|
| Cancer Cell Int Transcription elongation factor A-like 7, regulated by miR-758-3p inhibits the progression of melanoma through decreasing the expression levels of c-Myc and AKT1.
 | ||
| PLoS One Decreased expression of transcription elongation factor A-like 7 is associated with gastric adenocarcinoma prognosis. | 




